News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Addex Pharmaceuticals Raises $111.3 Million in IPO
May 22, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, May 21 (Reuters) - Addex Pharmaceuticals raised 137 million Swiss francs ($111.3 million) in its initial public offering on Monday to help bring its small molecule drugs to market.
Twitter
LinkedIn
Facebook
Email
Print
IPO
Europe
MORE ON THIS TOPIC
IPOs
UPDATE: MapLight Seeks $227M IPO for Neuropsych Portfolio
October 7, 2025
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
October 2, 2025
·
3 min read
·
Annalee Armstrong
Mergers & acquisitions
Q3 Saw Some of the Highest-Value Biopharma Acquisitions of the Year So Far
October 1, 2025
·
2 min read
·
Annalee Armstrong
Mergers & acquisitions
The Top Big Pharmas Have $1.2T in Stretch M&A Firepower Available
October 1, 2025
·
6 min read
·
Annalee Armstrong